儿童、青少年及年轻成人癌症幸存者的呼吸系统死亡率
该研究基于英国儿童癌症幸存者研究(BCCSS)和青少年及年轻成人癌症幸存者研究(TYACSS)两个队列,评估40岁前确诊癌症的5年幸存者的长期呼吸系统死亡风险。BCCSS纳入1940-2006年英国15岁前确诊的34 489例幸存者,TYACSS纳入1971-2006年英格兰和威尔士15-39岁确诊的200 945例幸存者。结果显示两个队列呼吸系统死亡分别为164例和1079例,标准化死亡比分别为6.8(95%CI 5.8-7.9)和1.7(95%CI 1.6-1.8),风险因呼吸系统死亡类型而异。
要点
- 儿童癌症幸存者呼吸系统死亡风险为一般人群的6.8倍,年轻成人幸存者为1.7倍。
- 呼吸系统超额死亡数随 attained age 增加,BCCSS 50岁以上超额7例,TYACSS 60岁以上超额3例。
- 近期诊断的幸存者呼吸系统超额死亡数呈下降趋势。
核心结论
- 儿童、青少年及年轻成人癌症幸存者长期呼吸系统死亡风险显著高于一般人群,且风险因呼吸系统死亡类型和原发肿瘤类型而异。
研究设计与样本
- 基于英国儿童癌症幸存者研究(BCCSS)和青少年及年轻成人癌症幸存者研究(TYACSS)的队列研究。
- BCCSS纳入1940-2006年英国15岁前确诊的34 489例癌症幸存者;TYACSS纳入1971-2006年英格兰和威尔士15-39岁确诊的200 945例癌症幸存者。
- 采用标准化死亡比和绝对超额风险进行分析。
主要发现
- BCCSS队列观察到164例呼吸系统死亡,标准化死亡比为6.8(95%CI 5.8-7.9)。
- TYACSS队列观察到1079例呼吸系统死亡,标准化死亡比为1.7(95%CI 1.6-1.8)。
- BCCSS中中枢神经系统肿瘤后超额死亡数最多;TYACSS中肺癌、白血病、头颈癌和中枢神经系统肿瘤后超额死亡数最多。
- BCCSS中50岁及以上者超额死亡7例(95%CI 2.4-11.3);TYACSS中60岁及以上者超额死亡3例(95%CI 1.4-4.2)。
- 两个队列中近期诊断者的呼吸系统超额死亡数均下降。
临床怎么用
- 对儿童、青少年及年轻成人癌症幸存者应关注长期呼吸系统健康,尤其在 attained age 增长后。
- 中枢神经系统肿瘤、肺癌、白血病、头颈癌幸存者可能是呼吸系统死亡高风险人群,需加强随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Exposure to radiation and/or chemotherapy during cancer treatment can compromise respiratory function. We investigated the risk of long-term respiratory mortality among 5-year cancer survivors diagnosed before age 40 years using the British Childhood Cancer Survivor Study (BCCSS) and Teenage and Young Adult Cancer Survivor Study (TYACSS). METHODS: The BCCSS comprises 34 489 cancer survivors diagnosed before 15 years from 1940 to 2006 in Great Britain. The TYACSS includes 200 945 cancer survivors diagnosed between 15 years and 39 years from 1971 to 2006 in England and Wales. Standardised mortality ratios and absolute excess risks were used. FINDINGS: Overall, 164 and 1079 respiratory deaths were observed in the BCCSS and TYACSS cohorts respectively, which was 6.8 (95% CI 5.8 to 7.9) and 1.7 (95% CI 1.6 to 1.8) times that expected, but the risks varied substantially by type of respiratory death. Greatest excess numbers of deaths were experienced after central nervous system (CNS) tumours in the BCCSS and after lung cancer, leukaemia, head and neck cancer and CNS tumours in the TYACSS. The excess number of respiratory deaths increased with increasing attained age, with seven (95% CI 2.4 to 11.3) excess deaths observed among those aged 50+ years in the BCCSS and three (95% CI 1.4 to 4.2) excess deaths observed among those aged 60+ years in the TYACSS. It was reassuring to see a decline in the excess number of respiratory deaths among those diagnosed more recently in both cohorts. CONCLUSIONS: Prior to this study, there was almost nothing known about the risks of respiratory death after cancer diagnosed in young adulthood, and this study addresses this gap. These new findings will be useful for both survivors and those involved in their clinical management and follow-up.
引用
- Fidler MM, Reulen RC, Bright CJ, et al. Respiratory mortality of childhood, adolescent and young adult cancer survivors. Thorax. 2018. PMID: 29748251. doi:10.1136/thoraxjnl-2017-210683
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。